Home/Filings/4/0000950170-23-012031
4//SEC Filing

Gibbs Michael Terrence 4

Accession 0000950170-23-012031

CIK 0001492674other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 1:08 PM ET

Size

4.4 KB

Accession

0000950170-23-012031

Insider Transaction Report

Form 4
Period: 2023-03-28
Gibbs Michael Terrence
General Counsel
Transactions
  • Sale

    Common Stock

    2023-03-28$0.48/sh239$1156,612 total
Footnotes (1)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2018.

Documents

1 file

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001665000

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 1:08 PM ET
Size
4.4 KB